Saphetor are taking part in the Genomics Unlocked Webinar Series, as part of a partnership with MGI Europe. The webinar, Clinical Exomes: Sequencing to Reporting, demonstrates the full clinical exome workflow from sample to report generation...

Abu Dhabi, October 24, 2022: In a step aimed at boosting its clinical genomics capabilities in the region and beyond, G42 Healthcare, Abu Dhabi-based leading AI health-tech company, has announced a partnership with Saphetor SA, a Swiss precision...

VarSome is exhibiting at this year's ASHG annual meeting in Los Angeles.

RIYADH, Kingdom of Saudi Arabia--(BUSINESS WIRE)--King Faisal Specialist Hospital and Research Centre (KFSH&RC) will integrate Saphetor’s proprietary human genome variant interpretation engine, VarSome, into its research and clinical genomics...

Lausanne, Switzerland - September 15, 2022 - Saphetor SA, a Switzerland-based precision medicine company recognized for its industry leading variant interpretation platform VarSome, has been successfully selected as one of the twelve companies to...

Lausanne, Switzerland - March 11, 2021 - Saphetor SA, a Swiss-based precision medicine company specializing in analysis and interpretation of genomic data, announced today a distribution agreement with BioCat GmbH, a leading provider of innovative...

Lausanne, Switzerland - February 25, 2021 - Saphetor SA, a Switzerland-based precision medicine company using bioinformatics to apply human genome data to benefit people, announced today a distribution agreement with Annar Health Technologies...

Lausanne, Switzerland - July 22, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with ELTA 90...

Lausanne, Switzerland - July 10, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Decode...

Lausanne, Switzerland - May 19, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with TATAA...

Lausanne, Switzerland - May 18, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Thunder...